You're viewing a public preview of this transaction Sign up free to access full investor details, deal amounts & seller data
Sign Up Free Log In
Deal Overview

ImmunoGen, Inc. (Add-on Acquistion, in 2024)

Transaction #139072
Investor
1
Sign up to view
Target Company
ImmunoGen, Inc.
Life Science · United States
Sellers
No seller data
10100 USD
Deal Value
30 Nov 2023
Announced
12 Feb 2024
Closed
Target Company
Company Sector Entity Type Status State Country
ImmunoGen, Inc. Life Science Private Inactive Massachusetts (MA) United States
Investors 1
InvestorInvestment TypeAmount% Holding
View 1 Investor
Sign up to access investor names, investment types, deal amounts and ownership percentages
Sign Up Free Log In
Sellers
Seller
View Sellers
Sign up free to access seller names and full exit details for this transaction
Sign Up Free Log In
Frequently Asked Questions
What is the ImmunoGen, Inc. acquisition deal?
This transaction is an acquisition of ImmunoGen, Inc. (Add-on Acquistion) in 2024. The target company operates in the Life Science sector. Full deal details are available on AcquityData.
When did the ImmunoGen, Inc. acquisition happen?
This transaction was announced on 30 Nov 2023 and closed on 12 Feb 2024.
What is the deal value of the ImmunoGen, Inc. acquisition?
The deal value for this transaction is 10100 USD.
Who are the investors in the ImmunoGen, Inc. transaction?
This transaction has 1 investor. Sign up to AcquityData to view investor names, investment types, amounts and ownership details.

Access the full ImmunoGen, Inc. deal profile

Unlock investor names, amounts, seller details and complete M&A intelligence in one connected platform.

Start Free Trial